Development of quality indicators to monitor radiotherapy care for men with prostate cancer: A modified Delphi method.
Radiother Oncol
; 128(2): 308-314, 2018 08.
Article
in En
| MEDLINE
| ID: mdl-29753551
ABSTRACT
BACKGROUND AND PURPOSE:
Quality indicators (QIs) have been developed for many aspects of prostate cancer care, but are under-developed with regard to radiotherapy treatment. We aimed to develop a valid, relevant and feasible set of core QIs to measure quality of radiotherapy care in men with prostate cancer. MATERIALS ANDMETHODS:
We used a RAND-modified Delphi process to select QIs that were regarded as both important and feasible measures of quality radiotherapy care. This involved two phases (1) a literature review to identify a list of proposed QIs; and (2) a QI selection process by an expert panel (nâ¯=â¯12) conducted in a series of three rounds two online questionnaires' and one face-to-face meeting. The RAND criterion identified variation in ratings and determined the level of agreement after each round of voting.RESULTS:
A total of 144 candidate QIs, which included measures from pre-treatment to post-treatment and survivorship care were identified. After three rounds of voting, the panel approved a comprehensive set of 17 QIs, with most assessing a process of care (nâ¯=â¯16, 94.1%) and the remaining assessing a health outcome.CONCLUSION:
This study developed a core set of 17 QIs which will be used to report from the Prostate Cancer Outcomes Registry-Australia & New Zealand, to monitor the quality of radiotherapy care prostate cancer patients receive.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Quality Indicators, Health Care
Type of study:
Evaluation_studies
/
Prognostic_studies
/
Qualitative_research
Limits:
Humans
/
Male
Language:
En
Journal:
Radiother Oncol
Year:
2018
Document type:
Article